Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells
- 31 January 2002
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 160 (1) , 49-58
- https://doi.org/10.1016/s0021-9150(01)00547-0
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Role and regulation of cyclooxygenase-2 during inflammationThe American Journal of Medicine, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosisJournal of the American College of Cardiology, 1998
- Cyclooxygenase in biology and diseaseThe FASEB Journal, 1998
- Stability and Instability: Two Faces of Coronary AtherosclerosisCirculation, 1996
- In vivo and in vitro expression of a non-mammalian cyclooxygenase-1Prostaglandins, 1996
- Coronary Plaque DisruptionCirculation, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.Circulation, 1994
- Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.Circulation, 1994